Sarepta Therapeutics (SRPT)
(Delayed Data from NSDQ)
$132.30 USD
-0.28 (-0.21%)
Updated May 9, 2024 04:00 PM ET
After-Market: $132.30 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.05 |
EPS Last Quarter | 0.73 |
Last EPS Surprise | 763.64% |
ABR | 1.50 |
Earnings ESP
|
-33.80% |
---|---|
Current Year | 2.68 |
Next Year | 7.98 |
EPS (TTM) | 0.47 |
P/E (F1) | 49.47 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 382.34M | 489.45M | 1.84B | 2.67B |
# of Estimates | 8 | 8 | 8 | 8 |
High Estimate | 412.50M | 705.54M | 2.42B | 4.07B |
Low Estimate | 365.60M | 406.91M | 1.57B | 1.67B |
Year ago Sales | 261.24M | 331.82M | 1.24B | 1.84B |
Year over Year Growth Est. | 46.35% | 47.50% | 48.23% | 44.93% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.05 | 0.90 | 2.68 | 7.98 |
# of Estimates | 8 | 6 | 7 | 7 |
Most Recent Consensus | -0.06 | 1.32 | 5.58 | 11.00 |
High Estimate | 0.07 | 2.00 | 6.10 | 13.43 |
Low Estimate | -0.12 | 0.29 | 0.89 | 0.52 |
Year ago EPS | -0.27 | -0.46 | -5.80 | 2.68 |
Year over Year Growth Est. | 81.48% | 295.65% | 146.21% | 197.60% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 3 | 1 | 2 |
Up Last 60 Days | 1 | 3 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 4 | 2 | 4 | 4 |
Down Last 60 Days | 4 | 2 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.05 | 0.90 | 2.68 | 7.98 |
7 Days Ago | -0.04 | 0.90 | 2.68 | 7.98 |
30 Days Ago | 0.16 | 0.91 | 2.76 | 9.49 |
60 Days Ago | 0.11 | 0.80 | 2.39 | 9.42 |
90 Days Ago | 0.69 | 1.10 | 2.67 | 9.74 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.07 | 1.02 | 3.39 | 9.22 |
Zacks Consensus Estimate | -0.05 | 0.90 | 2.68 | 7.98 |
Earnings ESP | -33.80% | 13.54% | 26.42% | 15.58% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.73 | 0.47 | -0.46 | -0.27 | NA |
Estimate | -0.11 | -0.03 | -1.66 | -1.89 | NA |
Difference | 0.84 | 0.50 | 1.20 | 1.62 | 1.04 |
Surprise | 763.64% | 1,666.67% | 72.29% | 85.71% | 647.08% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more